» Authors » C Miceli-Richard

C Miceli-Richard

Explore the profile of C Miceli-Richard including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 20
Citations 561
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Quartier P, Saadoun D, Belot A, Errera M, Kaplanski G, Kodjikian L, et al.
Rev Med Interne . 2023 May; 44(5):227-252. PMID: 37147233
This French National Diagnostic and Care Protocol (NDPC) includes both pediatric and adult patients with non-infectious chronic uveitis (NICU) or non-infectious recurrent uveitis (NIRU). NICU is defined as uveitis that...
2.
Poline J, Fogel O, Pajot C, Miceli-Richard C, Rybojad M, Galeotti C, et al.
J Eur Acad Dermatol Venereol . 2019 Sep; 34(2):340-348. PMID: 31541486
Background: Blau syndrome (BS) is a rare monogenic autoinflammatory disease caused by NOD2 mutations. BS classically presents in early childhood as a triad of granulomatous polyarthritis, uveitis and skin involvement....
3.
Belkhir R, Gestermann N, Koutero M, Seror R, Tost J, Mariette X, et al.
Scand J Immunol . 2013 Oct; 79(1):37-42. PMID: 24117612
Epigenetic deregulation of genes encoded on the X chromosome as reported for CD40L in lupus could explain the female predominance of autoimmune diseases. We compared CD40L expression on CD4(+) T...
4.
Gestermann N, Mekinian A, Comets E, Loiseau P, Puechal X, Hachulla E, et al.
Genes Immun . 2010 Jun; 11(5):432-8. PMID: 20535138
Signal transducer and activator of transcription 4 (STAT4) is a transcription factor mainly activated by interleukin 12, which promotes the secretion of type 2 interferon (IFN) by T-helper 1 cells....
5.
Sellam J, Miceli-Richard C, Gottenberg J, Proust A, Ittah M, Lavie F, et al.
Rheumatology (Oxford) . 2008 Feb; 47(4):437-41. PMID: 18296721
Objectives: Inhibitor of differentiation 3 (Id3)-deficient mice show sicca symptoms, lymphocyte infiltration of exocrine glands and positive anti-Ro/SSA and anti-La/SSB antibodies, all hallmarks of primary Sjögren's syndrome (pSS). The impairment...
6.
Lavie F, Miceli-Richard C, Ittah M, Sellam J, Gottenberg J, Mariette X
Scand J Immunol . 2008 Jan; 67(2):185-92. PMID: 18201372
We investigated B-cell activating factor of the tumour necrosis factor family (BAFF) level in peripheral blood mononuclear cells (PBMCs), monocytes and T cells from patients with primary Sjögren's syndrome (pSS)...
7.
Thirion M, Miceli-Richard C, Labetoulle M, Mariette X
Clin Exp Rheumatol . 2007 Dec; 25(5):791. PMID: 18078636
No abstract available.
8.
Puechal X, Miceli-Richard C, Mejjad O, Lafforgue P, Marcelli C, Solau-Gervais E, et al.
Ann Rheum Dis . 2007 Nov; 67(6):880-4. PMID: 18037625
Objective: To assess anti-tumour necrosis factor (anti-TNF) agents in patients with refractory systemic rheumatoid vasculitis (SRV). Methods: 1200 rheumatologists and internists were asked to provide medical files for patients with...
9.
Miceli-Richard C, Comets E, Verstuyft C, Tamouza R, Loiseau P, Ravaud P, et al.
Ann Rheum Dis . 2007 Aug; 67(4):478-84. PMID: 17673491
Objective: To determine whether tumour necrosis factor (TNF) gene polymorphisms and/or the shared epitope are genetic predictors of the response to adalimumab (ADA) in rheumatoid arthritis (RA). Methods: This ancillary...
10.
Carter K, Pluzhnikov A, Timms A, Miceli-Richard C, Bourgain C, Wordsworth B, et al.
Rheumatology (Oxford) . 2007 Jan; 46(5):763-71. PMID: 17259653
Objective: Ankylosing spondylitis (AS) is a debilitating chronic inflammatory condition with a high degree of familiality (lambda(s) = 82) and heritability (>90%) that primarily affects spinal and sacroiliac joints. Whole...